Stockreport

Structure Therapeutics: The Dark Horse In The Oral Obesity GLP-1 Arena [Seeking Alpha]

Structure Therapeutics Inc. - American Depositary Shares  (GPCR) 
PDF GPCR's valuation appears attractive given a $1B revenue estimate by 2031, but the investment is high risk, hinging on GSBR-1290's Phase IIb results. Competition is fi [Read more]